DOCSLIB.ORG

Non-Target Genes Regulate Mirnas-Mediated Migration Steering of Colorectal Carcinoma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Non-Target Genes Regulate Mirnas-Mediated Migration Steering of Colorectal Carcinoma Pathology & Oncology Research (2019) 25:559–566 https://doi.org/10.1007/s12253-018-0502-9 ORIGINAL ARTICLE Non-target Genes Regulate miRNAs-Mediated Migration Steering of Colorectal Carcinoma Sohair M. Salem1 & Ahmed R. Hamed2,3 & Alaaeldin G. Fayez1 & Ghada Nour Eldeen1,4 Received: 20 January 2018 /Accepted: 15 October 2018 /Published online: 25 October 2018 # Arányi Lajos Foundation 2018 Abstract MicroRNAs (miRNAs) trigger a two-layer regulatory network directly or through transcription factors and their co-regulators. Unlike miR-375, the role of miR-145 and miR-224 in inhibiting or driving cancer cell migration is controversial. This study is a step towards addressing the potential of miR-375, miR-145 and miR-224 expression modulation to inhibit colorectal carcinoma (CRC) cells migration in vitro through regulation of non-target genes VEGFA, TGFβ1, IGF1, CD105 and CD44. Transwell migration assay results revealed a significant subdue of migration ability of cells transfected with miR-375 and miR-145 mimics and miR-224 inhibitor. Real time PCR data showed that expression of VEGFA, TGFβ1, IGF1, CD105 and CD44 was downreg- ulated as a consequence of exogenous re-expression of miR-375 and inhibition of miR-224. On the other hand, ectopic expression of miR-145 did not affect VEGFA, TGFβ1 and CD44 expression, while it elevated CD105 and suppressed IGF1 expression. MAP4K4, a predicted target of miR-145, was validated as a target that could play a role in miR-145-mediated regulation of migration. At mRNA level, no change was observed in expression of MAP4K4 in cells with restored expression of miR-145, while western blotting analysis revealed a 25% reduction of protein level. By applying luciferase reporter assay, a significant decrease in luciferase activity was observed, supporting that miR-145 directly target 3’ UTR of MAP4K4. The study highlighted the involvement of non-target genes VEGFA, TGFβ1, IGF1, CD105 and CD44 in mediating anti- and pro-migratory effect of dmiR-375 an miR-224, respectively, and validated MAP4K4 as a direct target of anti-migratory miR-145. Keywords MiRNAs, colorectal carcinoma . Non-target genes . MAP4K4 . Migration Introduction (miRNAs) are small non-coding RNAs that usually bind to recognition sites on target mRNAs leading to either degrada- Colorectal cancer (CRC) is the third leading cause of cancer tion of the transcript, inhibition of translation or rapid death among adults. Targeting dysregulated pathways repre- deadenylation [20]. Many studies have linked a well-known sents the best way to improve cancer treatment and increase sub-cellular structure, the cytoplasmic processing bodies the overall survival in cancer patients [43]. MicroRNAs (PBs), to miRNA pathway [30]. MiRNAs have been shown to act as tumor suppressors by negatively regulating gene expression of oncogenic factors. Alternatively, oncomirs, * Sohair M. Salem miRNAs which down-regulate expression of tumor suppres- [email protected] sor genes, have been identified in a variety of cancer types [14]. MiRNAs provide new therapeutic targets for many dis- 1 Molecular Genetics and Enzymology Department, National eases, including cancer. The progress in selecting specific Research Centre, 33 El-Buhouth St., Dokki, Giza 12622, Egypt anti-miRNA inhibitor chemistries and delivery system sug- 2 Phytochemistry Department, National Research Centre, 33 gests that miRNA-based therapeutics may soon be applied in El-Buhouth St., Dokki, Giza 12622, Egypt the clinic [5, 32]. In the context of CRC, several miRNAs have 3 Biology Unit - Central Laboratory of Pharmaceutical and Drug been reported to regulate different cellular processes that con- Industries Research Division, National Research Centre, 33 trol migration and metastasis by inhibition of multiple target El-Buhouth St., Dokki, Giza 12622, Egypt genes [9, 37, 52, 53]. 4 Stem Cell Research Unit, National Research Centre, 33 El-Buhouth MiR-375 is down-regulated and evinces significant tumor St., Dokki, Giza 12622, Egypt suppressive properties in CRC tissue [12] and could predict 560 S. M. Salem et al. the metastatic potential of CRC patients [45]. It inhibited the MAP4K4 was demonstrated to play a central role in cell mi- proliferation, invasion and migration by directly targeting Sp1 gration and invasion through the JNK pathway [7, 26], and is transcription factor and regulating matrix metalloproteinase 2 regulated by miR-141 [16]andmiR-194 [43]. (MMP2) and epithelial-mesenchymal transition (EMT)-asso- The complexity of miRNAs is attributed to the ability of ciated genes [8]. Tumor suppressor miR-145 inhibited invasion single miRNA to fine-tune the expression of hundreds and metastasis in many cancers by targeting several genes [10] mRNAs, and the potential of each mRNA to be regulated by and was expressed at reduced levels in colon cancer epithelial hundreds of miRNAs [1] through the two-layer regulatory cells [27]. However, a study by Yuan et al. [47]demonstrateda network. in this network, miRNAs directly regulate the genes significant relation between miR-145 expression and lymph node by mRNA degradation or translational inhibition at the prima- metastasis of CRC. The potential function of miR-224 as onco- ry level of the regulatory cascade; whereas the secondary tar- gene or tumor suppressor remains contradictory. Previous data gets of miRNAs are the genes that regulated by miRNA- have founded that miR-224 was significantly up-regulated in targeted TFs [38]. This study is a step towards highlighting CRC tissue samples and associated with disease relapse and a the involvement of non-target genes VEGFA, TGFβ1, IGF1, relative poorer disease-free survival rate, suggesting the oncogen- CD105 and CD44 in mediating the anti - or pro-migratory ic role of miR-224 in the tumorigensis of CRC, and its prognostic effect of miR375, miR-145 and miR-224, and validating function as a novel biomarker for patients relapse [50]. In con- MAP4K4 as target of miR-145. trast, another study indicated a significantly lower expression level of miR-224 in CRC tissues than those in non-tumor tissues. The differences in miR-224 expression levels in the pathogenesis Methods of cancer were suggested to be related to mutation status of the adenomatous polyposis coli (APC) gene and racial and environ- Cell Line Propagation and Transient Transfection mental diversity [21]. Molecularly-targeted inhibitors that blocked migration me- Human CRC cell line HCT116 (ATCC®) was maintained as diators, therefore subdue cancer cell migration, would be ex- monolayer culture in RPMI-1640 medium supplemented with pected to be clinically beneficial to cancer patients [54]. One 10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml strep- of the most prominent angiogenic factors is vascular endothe- tomycin sulfate and 2 mM L-glutamine at 37 °C under a hu- lial growth factor (VEGF) that widely studied for its signifi- midified atmosphere of 5% CO2. HiPerFect transfection re- cant role in tumor growth, migration and metastasis [41]. agent, miScript miRNA mimic of miR-375 and miR-145 and Transforming growth factor β (TGFβ) pathway also plays a miScript miRNA inhibitor of miR-224 were purchased from pro-tumoral role [28] and promote migration and metastasis of Qiagen (Germany). Transfection was carried out according to colon cancer cell into the liver and lung [29]. TGFβ was found the manufacturer’s instructions. Briefly, cells were seeded, to cooperate in an autocrine/paracrine fashion with other sig- transfected with transfection complex of HiPerFect transfec- naling cascades, including VEGF, basic fibroblast growth fac- tion reagent and 5 nM miRNA mimic or 50 nM miRNA tor (bFGF), platelet-derived growth factor (PDGF), inhibitor diluted in serum free medium, and incubated until angiopoietin and Notch, to regulate migration [29, 33]. monitoring gene or protein expression. For co-transfection of Insulin-like growth factor (IGF) family molecules act through mimic and plasmid, HiPerFect transfection reagent was com- binding to IGF receptors (IGFRs) which are receptor tyrosine plexed with 400 ng plasmid DNA and 5 nM miR-145 mimic kinases (RTKs) and most frequently signal through phos- diluted in medium without serum or antibiotics. phatidylinositol 3-kinase (PI3K) and mitogen-activated pro- tein kinase (MAPK) dependent mechanisms [19, 40]. It was MiRNAs Target Prediction demonstrated that IGF1 signaling is important in mediating protease activation and cell migration and invasion, and it Bioinformatics algorithms MIRDB (http://mirdb.org)and combined with TGFβ signaling to bring about an EMT [40]. Target Scan (http://targetscan.org) were used to predict Endoglin/CD105 functions as a co-receptor for TGFβ1, it downstream targets of miRNAs. Mature sequences of specifically enhanced TGFβ1-induced phosphorylation of in- miRNAs were downloaded from miRBase and the 3’ UTR tracellular effectors Smad 1/5/8 and increased a Smad 1/5/8 sequence of human MAP4K4 was downloaded from Ensembl responsive promoter [22]. Expression of both TGFβ1 and genome browser. CD105 correlated with increased expression of tumor vascular marker CD44 [3]. Reverse Transcription and Real-Time PCR MAPK kinase kinase kinase isoform 4 (MAP4K4) is a serine/threonine (S/T) kinase belongs to the mammalian Total RNA, containing miRNA, was extracted from STE20/MAP4K family, which is associated with cell motility, transfected cells using Direct-zol™ RNA MiniPrep (Zymo rearrangement of the cytoskeleton, and cell growth [18]. Research) according to the manufacturer’s instructions. The
Load more

Recommended publications
  • Characterization of a Novel MAP4K4-SASH1 Kinase Cascade Regulating Breast Cancer Tumorigenesis and Metastasis
    Characterization of a Novel MAP4K4-SASH1 Kinase Cascade Regulating Breast Cancer Tumorigenesis and Metastasis Yadong Li Guizhou Medical University Daoqiu Wu The Aliated Hospital of Guizhou Medical University Jing Hou Guizhou Provincial People's Hospital Jing Zhang The Aliated Hospital of Guizhou Medical University Xing Zeng Chongqing Medical University Lian Chen Guizhou Medical University Xin Wan Guizhou Medical University Zhixiong Wu Guizhou medical university Jinyun Wang Guizhou Medical University Ke Wang Yongchuan Hospital of Chongqing Dan Yang The Aliated Hospital of Guizhou Medical University Hongyu Chen Guizhou Medical University Zexi Xu Guizhou medical university Lei Jia Guizhou Medical University Qianfan Liu Guizhou medical university Zhongshu Kuang Page 1/30 Fudan university Geli Jiang Chongqing Cancer Hospital Hui Zhang Chongqing Zhongshan Hospital Jie Luo Chongqing Cancer Hospital Wei Li Chongqing Cancer Hospital Xue Zou The Aliated Hospital of Guizhou Medical University Xiaohua Zeng Chongqing Cancer Hospital Ding'an Zhou ( [email protected] ) Guizhou Medical University https://orcid.org/0000-0002-6614-9321 Research Keywords: SASH1, MAP4K4, Tumorigenesis, Metastasis, Hormone-dependent breast cancers Posted Date: November 5th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-101160/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 2/30 Abstract Background: The SAM and SH3 domain containing protein 1(SASH1) was previously described as a candidate tumor-suppressor gene in breast cancer and colon cancer to mediate tumor metastasis and tumor growth. Howeverthe underlying mechanisms by which SASH1 implements breast cancer tumorigenesis and the question why SASH1 is downregulated in most solid cancers remain unexplored.
    [Show full text]
  • MAP4K Family Kinases Act in Parallel to MST1/2 to Activate LATS1/2 in the Hippo Pathway
    ARTICLE Received 19 Jun 2015 | Accepted 13 Aug 2015 | Published 5 Oct 2015 DOI: 10.1038/ncomms9357 OPEN MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway Zhipeng Meng1, Toshiro Moroishi1, Violaine Mottier-Pavie2, Steven W. Plouffe1, Carsten G. Hansen1, Audrey W. Hong1, Hyun Woo Park1, Jung-Soon Mo1, Wenqi Lu1, Shicong Lu1, Fabian Flores1, Fa-Xing Yu3, Georg Halder2 & Kun-Liang Guan1 The Hippo pathway plays a central role in tissue homoeostasis, and its dysregulation contributes to tumorigenesis. Core components of the Hippo pathway include a kinase cascade of MST1/2 and LATS1/2 and the transcription co-activators YAP/TAZ. In response to stimulation, LATS1/2 phosphorylate and inhibit YAP/TAZ, the main effectors of the Hippo pathway. Accumulating evidence suggests that MST1/2 are not required for the regulation of YAP/TAZ. Here we show that deletion of LATS1/2 but not MST1/2 abolishes YAP/TAZ phosphorylation. We have identified MAP4K family members—Drosophila Happyhour homologues MAP4K1/2/3 and Misshapen homologues MAP4K4/6/7—as direct LATS1/2-activating kinases. Combined deletion of MAP4Ks and MST1/2, but neither alone, suppresses phosphorylation of LATS1/2 and YAP/TAZ in response to a wide range of signals. Our results demonstrate that MAP4Ks act in parallel to and are partially redundant with MST1/2 in the regulation of LATS1/2 and YAP/TAZ, and establish MAP4Ks as components of the expanded Hippo pathway. 1 Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.
    [Show full text]
  • The MAP4K4-STRIPAK Complex Promotes Growth and Tissue Invasion In
    bioRxiv preprint doi: https://doi.org/10.1101/2021.05.07.442906; this version posted May 8, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 The MAP4K4-STRIPAK complex promotes growth and tissue invasion in 2 medulloblastoma 3 Jessica Migliavacca1, Buket Züllig1, Charles Capdeville1, Michael Grotzer2 and Martin Baumgartner1,* 4 1 Division of Oncology, Children’s Research Center, University Children’s Hospital Zürich, Zürich, 5 Switzerland 6 2 Division of Oncology, University Children’s Hospital Zürich, Zürich, Switzerland 7 8 *e-mail: [email protected] 9 10 Abstract 11 Proliferation and motility are mutually exclusive biological processes associated with cancer that depend 12 on precise control of upstream signaling pathways with overlapping functionalities. We find that STRN3 13 and STRN4 scaffold subunits of the STRIPAK complex interact with MAP4K4 for pathway regulation in 14 medulloblastoma. Disruption of the MAP4K4-STRIPAK complex impairs growth factor-induced 15 migration and tissue invasion and stalls YAP/TAZ target gene expression and oncogenic growth. The 16 migration promoting functions of the MAP4K4-STRIPAK complex involve the activation of novel PKCs 17 and the phosphorylation of the membrane targeting S157 residue of VASP through MAP4K4. The anti- 18 proliferative effect of complex disruption is associated with reduced YAP/TAZ target gene expression 19 and results in repressed tumor growth in the brain tissue. This dichotomous functionality of the STRIPAK 20 complex in migration and proliferation control acts through MAP4K4 regulation in tumor cells and 21 provides relevant mechanistic insights into novel tumorigenic functions of the STRIPAK complex in 22 medulloblastoma.
    [Show full text]
  • Application of a MYC Degradation
    SCIENCE SIGNALING | RESEARCH ARTICLE CANCER Copyright © 2019 The Authors, some rights reserved; Application of a MYC degradation screen identifies exclusive licensee American Association sensitivity to CDK9 inhibitors in KRAS-mutant for the Advancement of Science. No claim pancreatic cancer to original U.S. Devon R. Blake1, Angelina V. Vaseva2, Richard G. Hodge2, McKenzie P. Kline3, Thomas S. K. Gilbert1,4, Government Works Vikas Tyagi5, Daowei Huang5, Gabrielle C. Whiten5, Jacob E. Larson5, Xiaodong Wang2,5, Kenneth H. Pearce5, Laura E. Herring1,4, Lee M. Graves1,2,4, Stephen V. Frye2,5, Michael J. Emanuele1,2, Adrienne D. Cox1,2,6, Channing J. Der1,2* Stabilization of the MYC oncoprotein by KRAS signaling critically promotes the growth of pancreatic ductal adeno- carcinoma (PDAC). Thus, understanding how MYC protein stability is regulated may lead to effective therapies. Here, we used a previously developed, flow cytometry–based assay that screened a library of >800 protein kinase inhibitors and identified compounds that promoted either the stability or degradation of MYC in a KRAS-mutant PDAC cell line. We validated compounds that stabilized or destabilized MYC and then focused on one compound, Downloaded from UNC10112785, that induced the substantial loss of MYC protein in both two-dimensional (2D) and 3D cell cultures. We determined that this compound is a potent CDK9 inhibitor with a previously uncharacterized scaffold, caused MYC loss through both transcriptional and posttranslational mechanisms, and suppresses PDAC anchorage- dependent and anchorage-independent growth. We discovered that CDK9 enhanced MYC protein stability 62 through a previously unknown, KRAS-independent mechanism involving direct phosphorylation of MYC at Ser .
    [Show full text]
  • Transcriptome Analysis of Human Diabetic Kidney Disease
    ORIGINAL ARTICLE Transcriptome Analysis of Human Diabetic Kidney Disease Karolina I. Woroniecka,1 Ae Seo Deok Park,1 Davoud Mohtat,2 David B. Thomas,3 James M. Pullman,4 and Katalin Susztak1,5 OBJECTIVE—Diabetic kidney disease (DKD) is the single cases, mild and then moderate mesangial expansion can be leading cause of kidney failure in the U.S., for which a cure has observed. In general, diabetic kidney disease (DKD) is not yet been found. The aim of our study was to provide an considered a nonimmune-mediated degenerative disease unbiased catalog of gene-expression changes in human diabetic of the glomerulus; however, it has long been noted that kidney biopsy samples. complement and immunoglobulins sometimes can be de- — tected in diseased glomeruli, although their role and sig- RESEARCH DESIGN AND METHODS Affymetrix expression fi arrays were used to identify differentially regulated transcripts in ni cance is not clear (4). 44 microdissected human kidney samples. The DKD samples were The understanding of DKD has been challenged by multi- significant for their racial diversity and decreased glomerular ple issues. First, the diagnosis of DKD usually is made using filtration rate (~20–30 mL/min). Stringent statistical analysis, using clinical criteria, and kidney biopsy often is not performed. the Benjamini-Hochberg corrected two-tailed t test, was used to According to current clinical practice, the development of identify differentially expressed transcripts in control and diseased albuminuria in patients with diabetes is sufficient to make the glomeruli and tubuli. Two different Web-based algorithms were fi diagnosis of DKD (5). We do not understand the correlation used to de ne differentially regulated pathways.
    [Show full text]
  • Peripheral Insulin Resistance in ILK- Depleted Mice by Reduction of GLUT4 Expression
    234 2 M HATEM-VAQUERO and others ILK modifies whole-body 234:2 115–128 Research glucose homeostasis Peripheral insulin resistance in ILK- depleted mice by reduction of GLUT4 expression Marco Hatem-Vaquero1,2, Mercedes Griera1,2, Andrea García-Jerez1,2, Alicia Luengo1,2, Julia Álvarez3, José A Rubio3, Laura Calleros1,2, Diego Rodríguez-Puyol2,4,1,*, Manuel Rodríguez-Puyol1,2,* and Sergio De Frutos1,2,* 1Department of Systems Biology, Physiology Unit, Universidad de Alcalá, Madrid, Spain 2Instituto Reina Sofía de Investigación Renal and REDinREN from Instituto de Salud Carlos III, Madrid, Spain Correspondence 3Endocrinology and Nutrition Department, Hospital Príncipe de Asturias, Madrid, Spain should be addressed 4Biomedical Research Foundation and Nephrology Department, Hospital Príncipe de Asturias, Madrid, Spain to S De Frutos *(D Rodríguez-Puyol, M Rodríguez-Puyol and S De Frutos contributed equally to this work) Email [email protected] Abstract The development of insulin resistance is characterized by the impairment of glucose Key Words uptake mediated by glucose transporter 4 (GLUT4). Extracellular matrix changes are f integrin-linked kinase induced when the metabolic dysregulation is sustained. The present work was devoted f Glut4 Endocrinology to analyze the possible link between the extracellular-to-intracellular mediator f striated muscle of integrin-linked kinase (ILK) and the peripheral tissue modification that leads to glucose f white adipose tissue homeostasis impairment. Mice with general depletion of ILK in adulthood (cKD-ILK) f myotubes Journal maintained in a chow diet exhibited increased glycemia and insulinemia concurrently f insulin resistance with a reduction of the expression and membrane presence of GLUT4 in the insulin- f glucose uptake sensitive peripheral tissues compared with their wild-type littermates (WT).
    [Show full text]
  • Shrna-Targeted MAP4K4 Inhibits Hepatocellular Carcinoma Growth
    Published OnlineFirst December 30, 2010; DOI: 10.1158/1078-0432.CCR-10-0331 Clinical Cancer Human Cancer Biology Research ShRNA-Targeted MAP4K4 Inhibits Hepatocellular Carcinoma Growth An-Wen Liu1,2, Jing Cai2, Xiang-Li Zhao1, Ting-Hui Jiang1, Tian-Feng He1, Hua-Qun Fu2, Ming-Hua Zhu3, and Shu-Hui Zhang1 Abstract Purpose: Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) is overexpressed in many types of cancer. Herein, we aimed to investigate its expression pattern, clinical significance, and biological function in hepatocellular carcinoma (HCC). Experimental Design: MAP4K4 expression was examined in 20 fresh HCCs and corresponding nontumor liver tissues. Immunohistochemistry for MAP4K4 was performed on additional 400 HCCs, of which 305 (76%) were positive for hepatitis B surface antigens. The clinical significance of MAP4K4 expression was analyzed. MAP4K4 downregulation was performed in HCC cell lines HepG2 and Hep3B with high abundance of MAP4K4, and the effects of MAP4K4 silencing on cell proliferation in vitro and tumor growth in vivo were evaluated. Quantitative real-time PCR arrays were employed to identify the MAP4K4-regulated signaling pathways. Results: MAP4K4 was aberrantly overexpressed in HCCs relative to adjacent nontumor liver tissues. This overexpression was significantly associated with larger tumor size, increased histologic grade, advanced tumor stage, and intrahepatic metastasis, as well as worse overall survival and higher early recurrence rate. Knockdown of the MAP4K4 expression reduced cell proliferation, blocked cell cycle at S phase, and increased apoptosis. The antitumor effects of MAP4K4 silencing were also observed in vivo, manifested as retarded tumor xenograft growth. Furthermore, multiple tumor progression–related signaling pathways including JNK, NFkB, and toll-like receptors were repressed by MAP4K4 downregulation.
    [Show full text]
  • Activation of Diverse Signalling Pathways by Oncogenic PIK3CA Mutations
    ARTICLE Received 14 Feb 2014 | Accepted 12 Aug 2014 | Published 23 Sep 2014 DOI: 10.1038/ncomms5961 Activation of diverse signalling pathways by oncogenic PIK3CA mutations Xinyan Wu1, Santosh Renuse2,3, Nandini A. Sahasrabuddhe2,4, Muhammad Saddiq Zahari1, Raghothama Chaerkady1, Min-Sik Kim1, Raja S. Nirujogi2, Morassa Mohseni1, Praveen Kumar2,4, Rajesh Raju2, Jun Zhong1, Jian Yang5, Johnathan Neiswinger6, Jun-Seop Jeong6, Robert Newman6, Maureen A. Powers7, Babu Lal Somani2, Edward Gabrielson8, Saraswati Sukumar9, Vered Stearns9, Jiang Qian10, Heng Zhu6, Bert Vogelstein5, Ben Ho Park9 & Akhilesh Pandey1,8,9 The PIK3CA gene is frequently mutated in human cancers. Here we carry out a SILAC-based quantitative phosphoproteomic analysis using isogenic knockin cell lines containing ‘driver’ oncogenic mutations of PIK3CA to dissect the signalling mechanisms responsible for oncogenic phenotypes induced by mutant PIK3CA. From 8,075 unique phosphopeptides identified, we observe that aberrant activation of PI3K pathway leads to increased phosphorylation of a surprisingly wide variety of kinases and downstream signalling networks. Here, by integrating phosphoproteomic data with human protein microarray-based AKT1 kinase assays, we discover and validate six novel AKT1 substrates, including cortactin. Through mutagenesis studies, we demonstrate that phosphorylation of cortactin by AKT1 is important for mutant PI3K-enhanced cell migration and invasion. Our study describes a quantitative and global approach for identifying mutation-specific signalling events and for discovering novel signalling molecules as readouts of pathway activation or potential therapeutic targets. 1 McKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, 733 North Broadway, BRB 527, Baltimore, Maryland 21205, USA.
    [Show full text]
  • Inhibition of GCK-IV Kinases Dissociates Cell Death and Axon Regeneration in CNS Neurons
    Inhibition of GCK-IV kinases dissociates cell death and axon regeneration in CNS neurons Amit K. Patela, Risa M. Broyera, Cassidy D. Leea, Tianlun Lua, Mikaela J. Louieb, Anna La Torreb, Hassan Al-Alic,d,e, Mai T. Vua, Katherine L. Mitchellf, Karl J. Wahlina, Cynthia A. Berlinickef, Vinod Jaskula-Rangaf, Yang Hug, Xin Duanh, Santiago Vilarc, John L. Bixbyd,i,j, Robert N. Weinreba, Vance P. Lemmonc,e,j, Donald J. Zackf,k,l, and Derek S. Welsbiea,1 aViterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA 92093; bDepartment of Cell Biology and Human Anatomy, University of California, Davis, CA 95616; cTruvitech LLC, Miami, FL 33136; dThe Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami, Miami, FL 33136; ePeggy and Hardol Katz Family Drug Discovery Center, Department of Medicine, and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136; fWilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21287; gDepartment of Ophthalmology, Stanford University, Stanford, CA 94304; hDepartment of Ophthalmology, University of California, San Francisco, CA 94158; iDepartment of Molecular and Cellular Pharmacology, University of Miami, Miami, FL 33136; jCenter for Computational Sciences, University of Miami, Miami, FL 33136; kDepartment of Neuroscience, Molecular Biology and Genetics, Johns Hopkins University, Baltimore, MD 21287; and lDepartment of Genetic Medicine, Johns Hopkins University, Baltimore, MD 21287 Edited by Carol Ann Mason, Columbia University, New York, NY, and approved November 10, 2020 (received for review March 20, 2020) Axon injury is a hallmark of many neurodegenerative diseases, culminate in cell death.
    [Show full text]
  • Role of Microrna-141 in Colorectal Cancer with Lymph Node Metastasis
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 12: 3405-3410, 2016 Role of microRNA-141 in colorectal cancer with lymph node metastasis LI FENG1, HONGQING MA2, LIANG CHANG1, XINLIANG ZHOU1, NA WANG3, LIANMEI ZHAO4, JING ZUO1, YUDONG WANG1, JING HAN1 and GUIYING WANG2 1Department of Medical Oncology; 2Second Department of General Surgery; 3Department of Molecular Biology; 4Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China Received March 3, 2015; Accepted May 19, 2016 DOI: 10.3892/etm.2016.3751 Abstract. The present study aimed to investigate the role Introduction of microRNA (miR)-141 in the pathogenesis of colorectal cancer (CRC). In total, 58 CRC patients were included in the In China, the incidence and mortality rates of colorectal cancer present study. The mRNA and protein expression levels of (CRC) were 23.03/100,000 and 11.11/100,000, respectively, in mitogen-activated protein kinase 4 (MAP4K4) were detected 2011, ranking only after lung cancer and gastric cancer (1). As by reverse transcription-quantitative polymerase chain reac- a result of early stage CRC not displaying typical symptoms tion (RT-qPCR) and western blot analysis, respectively. The and signs associated with the disease, patients are predomi- miRNA-141 expression was measured by RT-qPCR, while nantly diagnosed at an advanced stage, often accompanied by serum MAP4K4 content was detected by enzyme-linked metastasis, thus missing the optimal time-frame for effective immunosorbent assay. Natural killer (NK) cells and T cells treatment (2). In general, lymph node metastasis represents the in peripheral blood were detected by flow cytometry. The first step of tumor dissemination for CRC, and lymph node results indicated that the mRNA and protein expression levels micrometastasis is currently an accurate indicator for the of MAP4K4 were significantly elevated in the tumor tissues, clinical staging, treatment and prognostic determination of lymph nodes (P<0.01) and serum (P<0.05) in CRC.
    [Show full text]
  • The Role of MAP4K4 in Cardiac Muscle Cell Death
    The role of MAP4K4 in cardiac muscle cell death Micaela M. Jenkins CID: 00855768 National Heart and Lung Institute Faculty of Medicine Imperial College London A Thesis submitted to Imperial College London for Doctor of Philosophy 1 National Heart and Lung Institute Word count: 65,028 2 Acknowledgements I express my sincerest thanks to Professor Michael Schneider and Professor Sian Harding for enabling the opportunity to work on this exciting project as well as for all their help, support and advice during course of my studies. I am also very grateful to the British Heart Foundation for awarding me the studentship to undertake this research. I would like to acknowledge the extensive work carried out by the MAP4K4 team past and present, which provided the foundations for this study. I am especially grateful to Lorna Fiedler for all her scientific and moral support all the way through from my MRes days to this day. Lorna’s insight into the project has been absolutely invaluable to me as has her guidance and support. I am extremely grateful to Dr Michela Noseda for imparting to me the research and technical skills necessary to complete the work hereby presented as well as for the daily support and guidance on every respect. I am indebted to Tom Owen, Eleanor Humphrey and Carolina Pinto Ricardo not only for their generous technical and academic assistance but also for accompanying me in the happy as well as hard moments during these three years. I would also like to thank all the members of the Schneider and Harding laboratories for their support and advice and for generally making my days at work so enjoyable.
    [Show full text]
  • MAP4K4 Controlled Integrin Β1 Activation and C-Met Endocytosis Are Associated with Invasive Behavior of Medulloblastoma Cells
    www.oncotarget.com Oncotarget, 2018, Vol. 9, (No. 33), pp: 23220-23236 Research Paper MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells Dimitra Tripolitsioti1, Karthiga Santhana Kumar1, Anuja Neve1, Jessica Migliavacca1, Charles Capdeville1, Elisabeth J. Rushing2, Min Ma1, Noriyuki Kijima3, Ashish Sharma4, Martin Pruschy4, Scott McComb1, Michael D. Taylor3, Michael A. Grotzer1,5 and Martin Baumgartner1 1University Children’s Hospital Zürich, Department of Oncology, Children’s Research Center, Zürich, Switzerland 2Institute of Neuropathology, University Hospital Zürich, Zürich, Switzerland 3Division of Neurosurgery, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada 4Department of Radiation Oncology, University Hospital Zürich, Zürich, Switzerland 5University Children’s Hospital Zürich, Department of Oncology, Zürich, Switzerland Correspondence to: Martin Baumgartner, email: [email protected] Keywords: medulloblastoma; MAP4K4; integrin β1; c-Met; cell migration and invasion Received: November 16, 2017 Accepted: April 08, 2018 Published: May 01, 2018 Copyright: Tripolitsioti et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Local tissue infiltration of Medulloblastoma (MB) tumor cells precedes metastatic disease but little is still known about intrinsic regulation of migration and invasion in these cells. We found that MAP4K4, a pro-migratory Ser/Thr kinase, is overexpressed in 30% of primary MB tumors and that increased expression is particularly associated with the frequently metastatic SHH β subtype. MAP4K4 is a driver of migration and invasion downstream of c-Met, which is transcriptionally up-regulated in SHH MB.
    [Show full text]